B of A Securities Initiates Coverage On Belite Bio with Buy Rating, Announces Price Target of $195
Benzinga Newsdesk 9 months ago
NewsPrice TargetInitiationAnalyst Ratings
B of A Securities analyst Tazeen Ahmad initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $195.
B of A Securities analyst Tazeen Ahmad initiates coverage on Belite Bio (NASDAQ:BLTE) with a Buy rating and announces Price Target of $195.